Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.66 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.66 |
| ▸ | GBA1 | P04062 | 12/20 | 0.64 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.63 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25516156 | 1.00 | HRH4 (0.66) | HRH4HRH3GBA1CYP19A1EPHX2 | |
| SCHEMBL25818947 | 1.00 | HRH4 (0.66) | HRH4HRH3GBA1CYP19A1EPHX2 | |
| SCHEMBL19501713 | 1.00 | HRH4 (0.66) | HRH4HRH3GBA1CYP19A1EPHX2 | |
| SCHEMBL11318961 | 1.00 | HRH4 (0.66) | HRH4HRH3GBA1CYP19A1EPHX2 | |
| SCHEMBL19663777 | 1.00 | HRH4 (0.66) | HRH4HRH3GBA1CYP19A1EPHX2 | |
| SCHEMBL24675720 | 1.00 | HRH4 (0.66) | HRH4HRH3GBA1CYP19A1EPHX2 | |
| SCHEMBL15944228 | 1.00 | HRH4 (0.66) | HRH4HRH3GBA1CYP19A1EPHX2 | |
| SCHEMBL15203072 | 1.00 | HRH4 (0.66) | HRH4HRH3GBA1CYP19A1EPHX2 | |
| SCHEMBL21959579 | 1.00 | HRH4 (0.66) | HRH4HRH3GBA1CYP19A1EPHX2 | |
| SCHEMBL25516157 | 1.00 | HRH4 (0.66) | HRH4HRH3GBA1CYP19A1EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 334 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2523651-B1 | WATER-RESISTANT COSMETIC FORMULATIONS COMPRISING A HYDROPHOBICALLY MODIFIED VINYLPYRROLIDONE COPOLYMER | BASF SE (DE) | 2020-03-11 | — | — | EP | claimed |
| WO-2016161493-A1 | TOPIC SUN-PROTECTION FORMULATIONS | ISP DO BRASIL LTDA (BR) | 2016-10-13 | — | — | WO | claimed |
| EP-1216690-B1 | Cosmetic and dermatological sunscreen compositions containing asymmetrically substituted triazine derivatives and citric esters surfactants | BEIERSDORF AG (DE) | 2012-07-25 | — | — | EP | claimed |
| EP-1453478-B1 | COSMETIC AND DERMATOLOGICAL LIGHT PROTECTIVE FORMULATIONS WITH A CONTENT OF PARTICULAR UV FILTER SUBSTANCES AND ALKYLNAPHTHALATES | BEIERSDORF AG (DE) | 2011-10-12 | — | — | EP | claimed |
| EP-1187598-B1 | MICROPIGMENT MIXTURE | BASF SE (DE) | 2009-10-21 | — | — | EP | claimed |
| US-20250092179-A1 | PHOTOSTABLE COMPOSITIONS COMPRISING PARA-ALKOXYL PHENYL SUBSTITUTED PROPENOIC ACID (APP) COPOLYMER DERIVATIVES | HallStar Beauty and Personal Care Innovations Company | 2025-03-20 | — | — | US | disclosed |
| US-20250000086-A1 | NEW MICROPARTICLES CONTAINING ACTIVE SUBSTANCES | BASF SE (DE) | 2025-01-02 | — | — | US | disclosed |
| US-12162972-B2 | Photostable compositions comprising para-alkoxyl phenyl substituted propenoic acid (APP) copolymer derivatives | HallStar Beauty and Personal Care Innovations Company (US) | 2024-12-10 | — | — | US | disclosed |
| EP-4398886-A1 | NEW MICROPARTICLES CONTAINING ACTIVE SUBSTANCES | BASF SE (DE) | 2024-07-17 | — | — | EP | disclosed |
| US-20240172746-A1 | NEW MICROPARTICLES CONTAINING ACTIVE SUBSTANCES | BASF SE (DE) | 2024-05-30 | — | — | US | disclosed |
| US-20240058782-A1 | New Microcapsules Containing Active Substances | BASF SE (DE) | 2024-02-22 | — | — | US | disclosed |
| US-20240026056-A1 | PHOTOSTABLE COMPOSITIONS COMPRISING PARA-ALKOXYL PHENYL SUBSTITUTED PROPENOIC ACID (APP) COPOLYMER DERIVATIVES | BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT | 2024-01-25 | — | — | US | disclosed |
| EP-1216690-A2 | Cosmetic and dermatological sunscreen compositions containing asymmetrically substituted triazine derivatives and citric esters surfactants | Beiersdorf AG (DE) | 2002-06-26 | — | — | EP | disclosed |
| EP-1216684-A1 | Self-foaming or foaming compositions comprising a lipidic phase | Beiersdorf AG (DE) | 2002-06-26 | — | — | EP | disclosed |
| EP-1214929-A2 | Use of polyurethanes for increasing the water-resistance of cosmetic or dermatological formulations | Beiersdorf Aktiengesellschaft (DE) | 2002-06-19 | — | — | EP | disclosed |
| EP-1213010-A2 | Use of water-soluble and film-forming polymers for increasing the light protection factor and/or the protection performance to UV-A in cosmetic or dermatological formulations | Beiersdorf AG (DE) | 2002-06-12 | — | — | EP | disclosed |
| EP-1210928-A1 | Cosmetically or dermatologically impregnated towelettes | Beiersdorf Aktiengesellschaft (DE) | 2002-06-05 | — | — | EP | disclosed |
| US-6355230-B2 | FOR ULTRAVIOLET-A RADIATION PROTECTION; SOLUBILITY | BEIERSDORF AG (DE) | 2002-03-12 | — | — | US | disclosed |
| US-20010026790-A1 | Cosmetic and dermatological light protection formulations wirh a content of benzotriazole derivatives and alkyl naphthalates | BEIERSDORF AG (DE) | 2001-10-04 | — | — | US | disclosed |
| EP-1127568-A2 | Cosmetic and dermatological light protective formulations containing benzotriazole derivatives and alkylnaphthalates | Beiersdorf AG (DE) | 2001-08-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240058782-A1 | New Microcapsules Containing Active Substances | PLA2G2C, PHOSPHO1, PSPH | HRH4 4624/4885HRH3 4250/4885GBA1 2486/4885 |
| US-20240172746-A1 | NEW MICROPARTICLES CONTAINING ACTIVE SUBSTANCES | SGMS1, SGMS2, LIPA | HRH4 4819/4885HRH3 4746/4885GBA1 724/4885 |
| US-12162972-B2 | Photostable compositions comprising para-alkoxyl phenyl substituted propenoic acid (APP) copolymer derivatives | APP, FAP, ANXA5 | HRH4 4248/4885HRH3 3811/4885GBA1 2824/4885 |
| US-20250000086-A1 | NEW MICROPARTICLES CONTAINING ACTIVE SUBSTANCES | SGMS1, PTDSS1, PLA2G2C | HRH4 4661/4885HRH3 4704/4885GBA1 1609/4885 |
| US-20250092179-A1 | PHOTOSTABLE COMPOSITIONS COMPRISING PARA-ALKOXYL PHENYL SUBSTITUTED PROPENOIC ACID (APP) COPOLYMER DERIVATIVES | APP, FAP, ANXA5 | HRH4 4248/4885HRH3 3811/4885GBA1 2824/4885 |
| US-20010026790-A1 | Cosmetic and dermatological light protection formulations wirh a content of benzotriazole derivatives and alkyl naphthalates | WHR1, WIZ, LBR | HRH4 74/4885HRH3 30/4885GBA1 2271/4885 |
| US-20240026056-A1 | PHOTOSTABLE COMPOSITIONS COMPRISING PARA-ALKOXYL PHENYL SUBSTITUTED PROPENOIC ACID (APP) COPOLYMER DERIVATIVES | APP, FAP, ANXA5 | HRH4 4248/4885HRH3 3811/4885GBA1 2824/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.